Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver injury all over the world. Its main characteristic is a fat accumulation in the liver, which is not due to alcohol abuse. This study was aimed at investigating the therapeutic and protective effect of a traditional, complementary product called the liver capsule on NAFLD. NAFLD was induced by a high-fat diet (HFD). Forty male Wistar rats were divided into eight groups; consisting of: standard control, HFD control, lifestyle modification, post-treatment, co-treatment, and treatment. The effectiveness of liver capsules was examined through assessment of liver enzymes, biochemical parameters, antioxidant levels, and lipid peroxidation.We also performed histological examination on liver tissues. Statistical analysis was performed, and p values less than 0.05 were considered significant. Treatment with l capsule lowered hepatic damage markers, serum glucose level, and serum lipid levels. Rats treated with liver capsule had enhanced antioxidant activity and reduced lipid peroxidation. The higher dose (10 mg/kg) presented lower levels in all the parameters mentioned. Longer duration of treatment in co-treatment groups caused an increase in oxidation activity. The liver capsule could not decrease biochemical markers to baseline in animals without lifestyle modification (p > 0.05). Accordingly, the liver capsule has both therapeutic and protective effects on NAFLD owing to multi-target mechanisms and can be a candidate for further assessments in clinical studies. Our traditional product showed a therapeutic effect, but it seems that lifestyle modification plays a key role in the therapeutic process for NAFLD.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
M. A. Ibrahim, M. Kelleni and A. Geddawy, Life Sci., 92(2), 114 – 118 (2013).
M. Gaggini, M. Morelli, E. Buzzigoli, et al., Nutrients, 5(5), 1544 – 1560 (2013).
N. Sattar, E. Forrest and D. Preiss, BMJ [Br. Med. J.], 349, g4596 (2014).
S. Bellentani, Liver Int., 37(Suppl 1), 81 – 84 (2017).
K. B. Lankarani, F. Ghaffarpasand, M. Mahmoodi, et al., Hepatitis Mon., 13(5), e9248 (2013).
F. Stickel and D. Schuppan, Dig. Liver Dis., 39(4), 293 – 304 (2007).
E. Shahkarami, B. Minaei and E. D. Jafari, Iran. J. Public Health, 42(7), 785 – 786 (2013).
F. Altinok-Yipel, I. Ozan Tekeli, S. Y. Ozsoy, et al., Int. J. Vitam. Nutr. Res., 90(3 – 4), 302 – 308 (2020).
H. M. Khan and S. Iqbal, Indian J. Pharm. Sci., 79(1) (2017).
S. Kumar, A. Kamboj and A. K. Sharma, Asian J. Pharm. Pharmacol., 4(2), 238 – 244 (2018).
R. Mohebbati, M. Paseban, F. Beheshti, et al., J. Pharmacopuncture, 21(4), 249 – 257 (2018).
S. K. Nikolaevna*, V. A. Kurkin, A. A. Shmygareva, et al., Int. J. Innovative Pharm. Sci. Res., 8(2), 1 – 8 (2020).
A. Rajopadhye and A. S. Upadhye, J. Evidence-Based Complementary Altern. Med., 2016, 4758734 (2016).
M. Sayyah, N. Hadidi and M. Kamalinejad, J. Ethnopharmacol., 92(2 – 3), 325 – 329 (2004).
B. Ahmed, S. Khan, M. H. Masood, et al., J. Asian Nat. Prod. Res., 10(3 – 4), 223 – 231 (2008).
K. Bellassoued, H. Hamed, F. Ghrab, et al., Arch. Physiol. Biochem., 127(6), 486 – 496 (2021).
T. Hussain, H. H. Siddiqui, S. Fareed, et al., Asian Pac. J. Trop. Biomed., 2(2), S995-S1001 (2012).
W. Rizvi, S. S. Naeem, O. Singh, et al., Med. Plants - Int. J. Phytomed. Relat. Ind., 9(3) (2017).
S. R. Mortazavi, M. Nassiri-Asl, Z. Farahani-Nick, et al., Pharmacologyonline, 3, 358 – 393 (2007).
M. M. Ramadan, N. N. E. A. A. H. H. El-kamali, K. Z. Ghanem, et al., World J. Med. Sci., 8(4), 322 – 333 (2013).
K. R. Anilakumar, F. Khanum and A. S. Bawa, J. Diet. Suppl., 7(1), 9 – 20 (2010).
A. E. Al-Snafi, IOSR J. Pharm., 6(7), 63 – 84 (2016).
P. Pushpangadan, T. P. Ijinu, V. M. Dan, et al., Ann. Phytomed., 4(2), 4 – 17 (2015).
N. A. A. Badr, Am. J. Sci., 7(3), 221 – 227 (2011).
N. Zamani, M. Shams, M. Nimrouzi, et al., Complementary Ther. Med., 41, 118 – 123 (2018).
R. Llorach, A. Martinez-Sanchez, F. A. Tomas-Barberan, et al., Food Chem., 108(3), 1028 – 1038 (2008).
C. Nicolle, N. Cardinault, E. Gueux, et al., Clin. Nutr., 23(4), 605 – 614 (2004).
H. Y. Tan, S. San-Marina, N. Wang, et al., J. Evidence-Based Complementary Altern. Med., 2016, 4750163 (2016).
J. Chen, M. Ma, Y. Lu, et al., Planta Med., 75(5), 472 – 477 (2009).
B. Ahmed, T. A. Al-Howiriny and A. B. Siddiqui, J. Ethnopharmacol., 87(2 – 3), 237 – 240 (2003).
N. Ziamajidi, S. Khaghani, G. Hassanzadeh, et al., Food Chem. Toxicol., 58, 198 – 209 (2013).
Y. Yue, S. Wu, H. Zhang, et al., Food Chem. Toxicol., 74, 76 – 84 (2014).
T. F. Tzeng, H. J. Lu, S. S. Liou, et al., Food Chem. Toxicol., 51, 194 – 201 (2013).
O. Odeja, G. Obi, C. Ogwuche, et al., Int. J. Herb. Med., 2(4), 26 – 30 (2014).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Albooyeh, S., Khadem, E., Jeivad, F. et al. Role of the Liver Capsule as a Traditional Medicine Formulation in the Treatment of Non-Alcoholic Fatty Liver Disease in Rats. Pharm Chem J 57, 1539–1545 (2024). https://doi.org/10.1007/s11094-024-03046-9
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11094-024-03046-9